MAI Capital Management’s Twist Bioscience TWST Stock Holding History

MAI Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-142	Closed	-$6.75K	–	4541
2026 Q1	$6.75K	Buy	142 +124	+689%	+$5.56K	﹤0.01%	3357
2025 Q4	$571	Hold	18	–	–	﹤0.01%	3799
2025 Q3	$507	Hold	18	–	–	﹤0.01%	3617
2025 Q2	$663	Hold	18	–	–	﹤0.01%	3721
2025 Q1	$707	Hold	18	–	–	﹤0.01%	3193
2024 Q4	$837	Buy	+18	New	+$813	﹤0.01%	3231

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

MAI Capital Management's TWST Position: Q2 2026 in Review

MAI Capital Management sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 142 shares — an estimated $6.75K sold.

MAI Capital Management first reported a position in TWST in Q4 2024 and held it in 6 quarters. The position peaked at $6.75K in Q1 2026. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

MAI Capital Management reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 142 Twist Bioscience shares in Q2 2026, an estimated $6.75K.
MAI Capital Management first reported a position in Twist Bioscience in Q4 2024 and held it in 6 quarters.
MAI Capital Management's Twist Bioscience position peaked at $6.75K in Q1 2026.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.